Merck MRK
NYSE MRK
$144.93 -2.60 (-1.76%)
As of: Sep 10, 2026 · 1:48 PM EDT

Merck (MRK) Operating Margin (QoQ) (2009 - 2026)

Analysis

Merck (MRK) Operating Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.98 Bn 621.22 Bn 17.26 Bn
2 AbbVie 446.60 Bn 440.03 Bn 12.70 Bn
3 Merck 357.75 Bn 350.61 Bn 12.21 Bn
4 Novartis Ag 267.43 Bn 259.74 Bn 11.24 Bn
5 Pfizer 156.61 Bn 144.91 Bn 10.94 Bn
6 Sanofi 52.22 Bn 44.84 Bn 10.79 Bn
7 Revolution Medicines 42.95 Bn 42.95 Bn -
8 Incyte 24.57 Bn 20.04 Bn 1.57 Bn
9 United Therapeutics 21.31 Bn 18.65 Bn 683.80 Mn
10 Neurocrine Biosciences 15.81 Bn 15.42 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,734.00
Mar 31, 2026 -6,712.00
Dec 31, 2025 860.00
Sep 30, 2025 608.00
Jun 30, 2025 -620.00
Mar 31, 2025 1,028.00
Dec 31, 2024 392.00
Sep 30, 2024 -1,396.00
Jun 30, 2024 180.00
Mar 31, 2024 2,098.00
Dec 31, 2023 -2,124.00
Sep 30, 2023 7,034.00
Jun 30, 2023 -6,015.00
Mar 31, 2023 95.00
Dec 31, 2022 -196.00
Sep 30, 2022 -693.00
Jun 30, 2022 -127.00
Mar 31, 2022 858.00
Dec 31, 2021 -1,017.00
Sep 30, 2021 2,246.00